Cargando…
P599: ACALABRUTINIB IMPROVES INNATE IMMUNE FUNCTION IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA
Autores principales: | Teglgaard, Rebecca, Rye Ostrowski, Sisse, Da Cunha-Bang, Caspar, Brieghel, Christian, Faitová, Tereza, Enggaard, Lisbeth, Jakob Hartling, Hans, Vibeke Hansen Marquart, Hanne, Utoft Niemann, Carsten |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429535/ http://dx.doi.org/10.1097/01.HS9.0000969300.20071.1d |
Ejemplares similares
-
Patients with CLL have a lower risk of death from COVID-19 in the Omicron era
por: Niemann, Carsten U., et al.
Publicado: (2022) -
Early stimulated immune responses predict clinical disease severity in hospitalized COVID-19 patients
por: Svanberg, Rebecka, et al.
Publicado: (2022) -
Author Correction: Early stimulated immune responses predict clinical disease severity in hospitalized COVID-19 patients
por: Svanberg, Rebecka, et al.
Publicado: (2023) -
Risk factors associated with Richter’s transformation in patients with chronic lymphocytic leukaemia: protocol for a retrospective population-based cohort study
por: Hleuhel, Mariam Hussein, et al.
Publicado: (2019) -
P629: THE CLL TREATMENT INFECTION MODEL – CLINICAL PROSPECTIVE VALIDATION AS PART OF THE PREVENT-ACALL TRIAL
por: Niemann, Carsten, et al.
Publicado: (2023)